Request that the Commissioner of the Food and Drug Administration declare that the drug product, Escitalopram Oxalate Tablets, 15 mg, is suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2026-P-4103
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.